Japans Megabanks Face Potential Headwinds After Record Profits L3Harris Technologies Stock Wall Street Weighs Bullish Defense Outlook Against Valuation Concerns Simbas Acquisition of M1 Collapses Singtel Shares Decline Amid Singapore Business Weakness Michael Saylor Tokenization Could Create Free Market for Credit Challenge Traditional Banking REX American Resources Posts Record Q1 Profitability Driven by Tax Credits and Lower Corn Costs Microsoft Appoints Jenny LayFlurrie as Lead of Trusted Technology Group to Steer Responsible AI Development STRRP Q1 2026 Earnings Missed Estimates with Significant EPS Shortfall HTZ Q1 2026 Earnings Narrower Loss Beats Estimates Amid Ongoing Operational Challenges FPI Q1 2026 Earnings EPS Misses Estimates Amidst Agricultural Market Challenges XPER Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 SLAI Q4 2024 Earnings EPS Misses Estimates as Company Reports Loss per Share Mercer International MERC Surges 69 as Buyers Step In Near Key Support Cohen Steers Infrastructure Fund UTF Edges Higher as Infrastructure Demand Remains Steady Atlanticus Holdings Senior Notes ATLCL Edge Lower as Yield Dynamics Weigh on FixedIncome Sentiment Super Group SGHC Shares Dip 263 as Stock Holds Near Key Support Level Syntec Optics Holdings Warrant OPTXW Rallies 105 Key Resistance Test Ahead Okta Inc OKTA Edges Higher as Cybersecurity Sector Shows Resilience BayCom Corp BCML Edges Higher Holding Above Key Support After Modest Advance Barings Participation Investors MPV Holds Steady Near Support in Modest Decline Esperion Therapeutics Holds Steady Near Support Testing Key Resistance Zone ESS Tech Inc GWH Gains 386 as Shares Test Key Resistance Near 101 Palisade Bio Inc PALI Edges Higher on Modest Volume Testing Resistance Levels New Tax Rules for Online Sellers and EV Buyers May Offer Savings This Season SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Tiziana Life Sciences TLSA Slips 265 as Stock Tests Key Support Zone